Our trusted team of thought leaders provides the latest insights and perspectives on important health industry and management consulting trends and topics.
To explore the critical intersection of Diversity, Equity, and Inclusion (DEI) with the Life Sciences supply chain.
Enhancing the performance of omnichannel activities is now a priority for many life sciences companies...
Read how a European-based regional HR organization within a Global Pharmaceutical company asked Vynamic to assess the current state of Diversity.
While awaiting approval to launch a new product, a large pharmaceutical company identified a need to revisit their market access strategy.
Vynamic brought strategic thinking, market expertise, and experience managing complex transformational programs to help a health insurer launch.
Patient centricity is no longer a buzzword. It’s redefining how the pharmaceutical industry operates. Watch how Vynamic strategically partnered.
Navigating changes in structure and responsibilities can present operational and cultural challenges for a team.
Enhancing the performance of omnichannel activities is now a priority for many life sciences companies.
Medical affairs plays a critical role in key activities for pharmaceutical companies. This includes evidence generation, evidence dissemination.
A global pharmaceutical company based in Europe needed to ensure robust and consistent product launch execution by Medical Affairs teams.
The US medical leadership team of a global life sciences company was faced with competing objectives based on changes in leadership.